Table 3.
Use of particular drugs in older people living in a nursing home or at home
| Drugs (ATC-5th level)a | Drug use prevalence (%) | Relative Risk (RR) | ||
|---|---|---|---|---|
| H (n = 48,944) | NH (n = 2313) | 95% CI | p-value | |
| Morphine | 0.3 | 4.5 | 13.7 (10.7, 17.4) | <0.01 |
| Oxycodone | 1.8 | 10.1 | 5.7 (4.9, 6.5) | <0.01 |
| Fentanyl | 0.5 | 6.2 | 12.4 (1.1, 15.2) | <0.01 |
| Buprenorphine | 1.1 | 11.9 | 10.7 (9.3, 12.3) | <0.01 |
| Codeine analgesics | 17.3 | 17.5 | 1.0 (0.9, 1.1) | 0.75 |
| Tramadol | 6.8 | 12.5 | 1.8 (1.6, 2.1) | <0.01 |
| Haloperidol | 0.3 | 4.1 | 15.8 (12.1, 20.6) | <0.01 |
| Clozapine, olanzapine, quetiapine | 0.8 | 5.3 | 6.9 (5.6, 8.4) | <0.01 |
| Risperidone | 0.4 | 5.4 | 14.0 (11.2, 17.5) | <0.01 |
| Oxazepam | 7.7 | 41.7 | 5.5 (5.2, 5.8) | <0.01 |
| Diazepam | 8.1 | 8.6 | 1.1 (0.9, 1.2) | 0.35 |
| Zopiclone, zolpidem | 27.3 | 39.8 | 1.5 (1.4, 1.5) | <0.01 |
| Clomethiazole | 0.1 | 8.5 | 68.8 (51.8, 91.4) | <0.01 |
| Citalopram, escitalopram sertraline, paroxetine | 6.4 | 19.7 | 3.1 (2.9, 3.4) | <0.01 |
| Mianserin, mirtazapine, venlafaxine | 4.6 | 14.8 | 3.2 (2.9 3.6) | <0.01 |
| Donepezil, rivastigmine, galantamine | 1.8 | 5.7 | 3.2 (2.7, 3.9) | <0.01 |
| Memantine | 0.4 | 5.7 | 15.0 (12.1, 18.7) | <0.01 |
H (home population), NH (nursing home population). RR (relative risk with 95% confidence interval and p-value and the population living at home as the reference group)
aDrugs with prevalence rates ≥4% in at least one of the populations